CEACAMP5

Across TCGA pan-cancer cohorts, CEACAMP5 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CEACAMP5 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher CEACAMP5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CEACAMP5 expression acts as an unfavorable survival marker, although some lineages such as UVM and LUSC show a favorable association.

THCA, ACC, and UVM are the cancer types where CEACAMP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Median	All	0.755	0.899	<.001	75	view →
ACC	OS	Median	All	0.411	0.836	<.001	70	view →
UVM	OS	Median	All	0.969	0.729	<.001	62	view →
LUSC	OS	Quartile	All	0.774	0.611	.002	35	view →
BLCA	OS	Median	All	0.729	0.461	.002	34	view →
LUAD	OS	Tertile	III,IV	0.856	0.578	.017	33	view →
UCEC	DFS	Tertile	All	0.854	0.918	<.001	32	view →
UCS	OS	Tertile	IV	0.206	0.781	.024	30	view →
PAAD	OS	Tertile	II,III,IV	0.561	0.273	.003	26	view →
KICH	OS	Tertile	All	0.906	1.000	.020	25	view →
HNSC	OS	Quartile	IV	0.796	0.564	.010	25	view →
BRCA	DFS	Quartile	All	0.421	0.528	.016	21	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

CEACAMP5–THCA (DFS)

Open the THCA breakdown →